ALMDT — Median Technologies SA Share News
0.000.00%
Last trade - 00:00- €148.23m
- €152.33m
- €23.36m
France's Median Technologies H1 order backlog rises on demand from biopharmaceutical clients
Brief: Median Technologies H1 Revenue EUR 11.8 Million
Brief: Median Launches Eur 40 Mln Capital Raise To Fund Eyonis Rollout, Extend Runway To H1 2028
Brief: Median Technologies Reports FY Revenue EUR 23.5 Million
France's Median Technologies reports 2025 revenue up 2.6%, record-high order backlog
Brief: Median Technologies Q3 Revenue EUR 5.9 Million
Europe Research Roundup: Burberry, Phoenix, Volkswagen
Street View: BNY Mellon looks resilient amid market uncertainty
Brief: Median Technologies Says U.S. FDA Filing For Eyonis LCS On Track For May 2025
Street View: Exxon to grow, but concerns remain over spending, chemicals unit
Street View: BNY to see positive business momentum heading into 2025
Brief: Median Technologies Announces Pivotal Reality Study Of Its Eyonis™ Lcs Lung Cancer Diagnostic Met All Primary And Secondary Endpoints
Street View: Deere's double-digit fall in EOP offers insight into 2025 demand
Europe Research Roundup: Ceconomy, Groupe, Teleperformance
Street View: ConocoPhillips checks all boxes for sustained outperformance
Brief: Median Technologies FY Revenue Drops To 22.2 Million Euros
Brief: Median Technologies Reports Results From Its Independent Verification Study
Brief: Median Technologies For Support Under French Government's Etincelles Program
Brief: Median Technologies Posts H1 Operating Loss Of EUR 11.2 Million